技術指標
指標
數值
方向
MACD(12,26,9)
-0.147
中性
RSI(14)
53.736
中性
STOCH(KDJ)(9,3,3)
59.081
買入
ATR(14)
2.781
高波動
CCI(14)
-3.231
中性
Williams %R
49.274
中性
TRIX(12,20)
0.120
賣出
StochRSI(14)
79.660
賣出
搜尋
Dexcom Inc
DXCM添加自選
83.450USD
+8.910+11.95%
收盤 07-30 16:00（美東）報價延遲15分鐘
32.20B總市值
34.89本益比TTM
關鍵數據
80.000今開
84.700最高
11.94M成交量
34.89本益比TTM
27.17本益比動
--股利TTM
3.09%換手率
74.540昨收
79.665最低
702.01M成交額
55.89本益比靜
10.89市淨率
0.00%股息率 TTM
13.90%ROA
89.98052週最高
2.50量比
576.20M淨利潤
385.90M總股本
2.3918每股盈餘TTM
1.44Beta
35.62%ROE
54.11052週最低
6.75%振幅
63.44%毛利率
32.20B總市值
2.08回報/風險
2.22%風險率
TradingKey Dexcom Inc股票評分
單位: USD 更新時間: 2026-07-30操作建議
Dexcom Inc當前公司基本面數據相對非常健康，增長潛力很大。當前估值合理，在醫療設備與耗材行業排名15/199位。機構持股佔比非常高，近一月多位分析師給出公司評級為買入。最高目標價為86.50。中期看，股價處於上升通道。近一個月，市場表現一般，但基本面評分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
Dexcom Inc評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
15°C
過冷
過熱
中性
Dexcom Inc亮點
亮點風險
DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.
業績高增長
公司營業收入穩步增長，連續3年增長28.70%
利潤高增長
公司淨利潤處於行業前列，最新年度總收入4.66B美元
估值低估
公司最新PE估值31.16，處於3年歷史低位
機構減倉
最新機構持股384.48M股，環比減少5.90%
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉，最新持倉0.00股
活躍度降低
近期活躍度降低，過去20天平均換手率-0.07
分析師目標
基於
30
分析師
買入
評級
86.498
目標均價
+17.89%
漲幅空間
Dexcom Inc新聞
即將為您帶來更多新聞，敬請期待。 。 。
收益預測
分析師評級
基於
30
分析師
買入
評級
86.498
目標均價
+15.12%
漲幅空間
強力買入
買入
持有
賣出
強力賣出
同行比較
109
總數
7
中位數
9
平均值
公司名稱
評級分佈
分析師數
Dexcom Inc
DXCM
30
Medtronic PLC
MDT
33
Zimmer Biomet Holdings Inc
ZBH
31
Stryker Corp
SYK
30
Medline Ord Shs Class A
MDLN
29
亞培
ABT
29
1
2
3
...
22
技術指標
移動平均線
指標
數值
方向
MA5
73.888
買入
MA10
73.844
買入
MA20
73.943
買入
MA50
72.803
買入
MA100
67.987
買入
MA200
67.655
買入
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Dexcom Inc簡介
DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.
公司代碼DXCM
公司Dexcom Inc
CEOMr. Jacob Steven (Jake) Leach
網址https://www.dexcom.com/
公司股東
相關品種
-1.69%
-0.46%
+0.12%
-0.57%
-0.75%
+0.13%
-6.42%
-0.35%
+1.72%
-0.17%
-2.98%
+1.54%
-0.29%
-0.98%
+0.13%
+0.06%
-0.84%
-0.24%
-0.69%
-0.78%熱門品種
52506.200
+237.200 (+0.45%)
28270.000
+71.500 (+0.25%)
7492.600
+48.300 (+0.65%)
14761.000
-78.000 (-0.53%)
63058.000
-536.000 (-0.84%)
6365.400
-1.000 (-0.02%)
83.694
+0.524 (+0.63%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4051.330
-51.500 (-1.25%)
常見問題
Dexcom Inc(DXCM)的當前股價是多少？
Dexcom Inc(DXCM)的當前股價是 74.57。
Dexcom Inc 的股票代碼是什麼？
Dexcom Inc的股票代碼是DXCM。
Dexcom Inc股票的52週最高點是多少？
Dexcom Inc股票的52週最高點是89.98。
Dexcom Inc股票的52週最低點是多少？
Dexcom Inc股票的52週最低點是54.11。
Dexcom Inc的市值是多少？
Dexcom Inc的市值是28.78B。
現在Dexcom Inc(DXCM)的股票是買入、持有還是賣出？
根據分析師評級，Dexcom Inc(DXCM)的總體評級為買入，目標價格為86.50。
Dexcom Inc(DXCM)股票的每股收益（EPS TTM）是多少
Dexcom Inc(DXCM)股票的每股收益（EPS TTM）是2.14。